Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation toolJ.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
Background: To characterise the population pharmacokinetics of tacrolimus in paediatric BMT recipients and to develop a dosing tool to assist with initial dosage selection.
Material/Methods: Data were collected retrospectively from the medical records of 22 children. Tacrolimus treatment started 36 hours pre-transplant as a continuous intravenous infusion of 0.03 mg/kg/day. Patients were converted to oral therapy two to three weeks post-transplant. Population pharmacokinetic analysis was performed using NONMEM. A macro was constructed in MS Excel, utilising Bayesian forecasting techniques and the population model, to recommend an initial dose in new individuals in order to achieve a target concentration of 12 ng/ml at the time of transplantation.
Results: 743 blood concentration-time points were analysed. Data were collected for a median of 95 days post transplant. All 514 samples collected during oral therapy represented trough values, and samples during infusion were collected 3 times/week. A one-compartment model with first order absorption and elimination was selected. In the final model, typical parameter values were clearance (CL) = 0.135L/h/kg0.75, distribution volume (V) =7.09L/kg and bioavailability (F) = 14.4%. Inter-individual variability in CL, V and F was 56%, 97% and 58%, respectively. Covariate analysis suggested CL positively correlated with creatinine clearance and F decreased with time post-transplant. Use of the model in the Macro, based on a 'typical patient' indicated a 50% higher dose than that currently used initially (0.03 mg/kg/day) is needed to achieve the target trough concentration.
Conclusions: The developed dosage adaptation tool may assist with tacrolimus dosing in paediatric BMT recipients, utilizing TDM concentrations.
Keywords: Creatinine, Tacrolimus, NONMEM
20 Jan 2022 : Original articleImpact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Ki...
Ann Transplant In Press; DOI: 10.12659/AOT.934850
19 Jan 2022 : Original articleCarbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in He...
Ann Transplant In Press; DOI: 10.12659/AOT.933420
18 Jan 2022 : Original articlePLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells
Ann Transplant In Press; DOI: 10.12659/AOT.933246
Most Viewed Current Articles
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
22 Dec 2021 : Original articleComparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...
Ann Transplant 2021; 26:e934163
12 Jan 2022 : Original articleRisk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...
Ann Transplant 2022; 27:e934738